Eli Lilly has introduced a fresh application that enables self-pay out people to purchase the weight-loss drug Zepbound for as minimal as $399 per month—under half the record price of other incretin medicines useful for clients with obesity.Mounjaro is a twin-action GLP-one/GIP medication named tirzepatide that may be prescribed for weight loss,